A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism

Ariel Pribluda; Ela Elyada; Zoltan Wiener; Haya Hamza; Robert E. Goldstein; Moshe Biton; Ido Burstain; Yael Morgenstern; Guy Brachya; Hana Billauer; Sharon Biton; Irit Snir-Alkalay; Domagoj Vucic; Katharina Schlereth; Marco Mernberger; Thorsten Stiewe; Moshe Oren; Kari Alitalo; Eli Pikarsky; Yinon Ben-Neriah

doi:10.1016/j.ccr.2013.06.005

A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism

Ariel Pribluda, Ela Elyada, Zoltan Wiener, Haya Hamza, Robert E. Goldstein, Moshe Biton, Ido Burstain, Yael Morgenstern, Guy Brachya, Hana Billauer, Sharon Biton, Irit Snir-Alkalay, Domagoj Vucic, Katharina Schlereth, Marco Mernberger, Thorsten Stiewe, Moshe Oren, Kari Alitalo, Eli Pikarsky, Yinon Ben-Neriah^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

189 Scopus citations

Abstract

Senescence, perceived as a cancer barrier, is paradoxically associated with inflammation, which promotes tumorigenesis. Here, we characterize a distinct low-grade inflammatory process in stressed epithelium that is related to para-inflammation; this process either represses or promotes tumorigenesis, depending on p53 activity. Csnk1a1 (CKIα) downregulation induces a senescence-associated inflammatory response (SIR) with growth arrest in colorectal tumors, which loses its growth control capacity in the absence of p53 and instead, accelerates growth and invasiveness. Corresponding processes occur in CKIα-deleted intestinal organoids, assuming tumorigenic transformation properties exvivo, upon p53 loss. Treatment of organoids and mice with anti-inflammatory agents suppresses the SIR and prevents p53-deficient organoid transformation and mouse carcinogenesis. SIR/para-inflammation suppression may therefore constitute a key mechanism in the anticarcinogenic effects of nonsteroidal anti-inflammatory drugs.

Original language	English
Pages (from-to)	242-256
Number of pages	15
Journal	Cancer Cell
Volume	24
Issue number	2
DOIs	https://doi.org/10.1016/j.ccr.2013.06.005
State	Published - 12 Aug 2013

Bibliographical note

Funding Information:
This work was supported by grants from the Israel Science Foundation-Centers of Excellence, the European Research Council within the FP-7: LIVERMICROENV (to E.P.), P73CANCER (to T.S.), and PICHO (to Y.B.-N.); the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the I-CORE program of ISF (grant no. 41/11); the Israel Cancer Research fund; the Alvarez Family award; the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum; the ERC Marie Curie Program and the Sigrid Juselius Foundation (to Z.W. and K.A.); and Israeli’s Ministry of Science, Culture and Sport. We thank Eva and George Klein for helpful insights clarifying our thoughts and terminology.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ccr.2013.06.005

Cite this

Pribluda, A., Elyada, E., Wiener, Z., Hamza, H., Goldstein, R. E., Biton, M., Burstain, I., Morgenstern, Y., Brachya, G., Billauer, H., Biton, S., Snir-Alkalay, I., Vucic, D., Schlereth, K., Mernberger, M., Stiewe, T., Oren, M., Alitalo, K., Pikarsky, E., & Ben-Neriah, Y. (2013). A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell, 24(2), 242-256. https://doi.org/10.1016/j.ccr.2013.06.005

@article{049962dba3944a9486c23770f504fc6b,

title = "A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism",

abstract = "Senescence, perceived as a cancer barrier, is paradoxically associated with inflammation, which promotes tumorigenesis. Here, we characterize a distinct low-grade inflammatory process in stressed epithelium that is related to para-inflammation; this process either represses or promotes tumorigenesis, depending on p53 activity. Csnk1a1 (CKIα) downregulation induces a senescence-associated inflammatory response (SIR) with growth arrest in colorectal tumors, which loses its growth control capacity in the absence of p53 and instead, accelerates growth and invasiveness. Corresponding processes occur in CKIα-deleted intestinal organoids, assuming tumorigenic transformation properties exvivo, upon p53 loss. Treatment of organoids and mice with anti-inflammatory agents suppresses the SIR and prevents p53-deficient organoid transformation and mouse carcinogenesis. SIR/para-inflammation suppression may therefore constitute a key mechanism in the anticarcinogenic effects of nonsteroidal anti-inflammatory drugs.",

author = "Ariel Pribluda and Ela Elyada and Zoltan Wiener and Haya Hamza and Goldstein, {Robert E.} and Moshe Biton and Ido Burstain and Yael Morgenstern and Guy Brachya and Hana Billauer and Sharon Biton and Irit Snir-Alkalay and Domagoj Vucic and Katharina Schlereth and Marco Mernberger and Thorsten Stiewe and Moshe Oren and Kari Alitalo and Eli Pikarsky and Yinon Ben-Neriah",

note = "Funding Information: This work was supported by grants from the Israel Science Foundation-Centers of Excellence, the European Research Council within the FP-7: LIVERMICROENV (to E.P.), P73CANCER (to T.S.), and PICHO (to Y.B.-N.); the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the I-CORE program of ISF (grant no. 41/11); the Israel Cancer Research fund; the Alvarez Family award; the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum; the ERC Marie Curie Program and the Sigrid Juselius Foundation (to Z.W. and K.A.); and Israeli{\textquoteright}s Ministry of Science, Culture and Sport. We thank Eva and George Klein for helpful insights clarifying our thoughts and terminology. ",

year = "2013",

month = aug,

day = "12",

doi = "10.1016/j.ccr.2013.06.005",

language = "אנגלית",

volume = "24",

pages = "242--256",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "2",

}

Pribluda, A, Elyada, E, Wiener, Z, Hamza, H, Goldstein, RE, Biton, M, Burstain, I, Morgenstern, Y, Brachya, G, Billauer, H, Biton, S, Snir-Alkalay, I, Vucic, D, Schlereth, K, Mernberger, M, Stiewe, T, Oren, M, Alitalo, K, Pikarsky, E & Ben-Neriah, Y 2013, 'A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism', Cancer Cell, vol. 24, no. 2, pp. 242-256. https://doi.org/10.1016/j.ccr.2013.06.005

TY - JOUR

T1 - A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism

AU - Pribluda, Ariel

AU - Elyada, Ela

AU - Wiener, Zoltan

AU - Hamza, Haya

AU - Goldstein, Robert E.

AU - Biton, Moshe

AU - Burstain, Ido

AU - Morgenstern, Yael

AU - Brachya, Guy

AU - Billauer, Hana

AU - Biton, Sharon

AU - Snir-Alkalay, Irit

AU - Vucic, Domagoj

AU - Schlereth, Katharina

AU - Mernberger, Marco

AU - Stiewe, Thorsten

AU - Oren, Moshe

AU - Alitalo, Kari

AU - Pikarsky, Eli

AU - Ben-Neriah, Yinon

N1 - Funding Information: This work was supported by grants from the Israel Science Foundation-Centers of Excellence, the European Research Council within the FP-7: LIVERMICROENV (to E.P.), P73CANCER (to T.S.), and PICHO (to Y.B.-N.); the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the I-CORE program of ISF (grant no. 41/11); the Israel Cancer Research fund; the Alvarez Family award; the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum; the ERC Marie Curie Program and the Sigrid Juselius Foundation (to Z.W. and K.A.); and Israeli’s Ministry of Science, Culture and Sport. We thank Eva and George Klein for helpful insights clarifying our thoughts and terminology.

PY - 2013/8/12

Y1 - 2013/8/12

N2 - Senescence, perceived as a cancer barrier, is paradoxically associated with inflammation, which promotes tumorigenesis. Here, we characterize a distinct low-grade inflammatory process in stressed epithelium that is related to para-inflammation; this process either represses or promotes tumorigenesis, depending on p53 activity. Csnk1a1 (CKIα) downregulation induces a senescence-associated inflammatory response (SIR) with growth arrest in colorectal tumors, which loses its growth control capacity in the absence of p53 and instead, accelerates growth and invasiveness. Corresponding processes occur in CKIα-deleted intestinal organoids, assuming tumorigenic transformation properties exvivo, upon p53 loss. Treatment of organoids and mice with anti-inflammatory agents suppresses the SIR and prevents p53-deficient organoid transformation and mouse carcinogenesis. SIR/para-inflammation suppression may therefore constitute a key mechanism in the anticarcinogenic effects of nonsteroidal anti-inflammatory drugs.

AB - Senescence, perceived as a cancer barrier, is paradoxically associated with inflammation, which promotes tumorigenesis. Here, we characterize a distinct low-grade inflammatory process in stressed epithelium that is related to para-inflammation; this process either represses or promotes tumorigenesis, depending on p53 activity. Csnk1a1 (CKIα) downregulation induces a senescence-associated inflammatory response (SIR) with growth arrest in colorectal tumors, which loses its growth control capacity in the absence of p53 and instead, accelerates growth and invasiveness. Corresponding processes occur in CKIα-deleted intestinal organoids, assuming tumorigenic transformation properties exvivo, upon p53 loss. Treatment of organoids and mice with anti-inflammatory agents suppresses the SIR and prevents p53-deficient organoid transformation and mouse carcinogenesis. SIR/para-inflammation suppression may therefore constitute a key mechanism in the anticarcinogenic effects of nonsteroidal anti-inflammatory drugs.

UR - http://www.scopus.com/inward/record.url?scp=84881526073&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2013.06.005

DO - 10.1016/j.ccr.2013.06.005

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 23890787

AN - SCOPUS:84881526073

SN - 1535-6108

VL - 24

SP - 242

EP - 256

JO - Cancer Cell

JF - Cancer Cell

IS - 2

ER -

A Senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this